{"id":49779,"date":"2022-10-18T23:02:11","date_gmt":"2022-10-18T21:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/"},"modified":"2022-10-18T23:02:11","modified_gmt":"2022-10-18T21:02:11","slug":"multiplan-corporation-announces-third-quarter-2022-earnings-conference-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/","title":{"rendered":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–MultiPlan Corporation (NYSE:MPLN) (\u201cMultiPlan\u201d or the \u201cCompany\u201d), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, and hold its conference call that morning at 8:00 a.m. Eastern Time.\n<\/p>\n

<\/a><\/p>\n

\nInvestors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the call start time.\n<\/p>\n

\nTo pre-register, go to: https:\/\/www.netroadshow.com\/events\/login?show=c4404ef1&confId=42446<\/a>.\n<\/p>\n

\nA live webcast of the conference call can be accessed through the Investor Relations section of the Company\u2019s website at investors.multiplan.com\/events-and-presentations<\/a>. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck will also be available on this section of the Company\u2019s website.\n<\/p>\n

\nFor those unable to listen to the live conference call, a replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company\u2019s website or by dialing (866) 813-9403 or (929) 458-6194. The replay access code is 004428.\n<\/p>\n

\nAbout MultiPlan<\/b>\n<\/p>\n

\nMultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients’ needs and customizes innovative solutions that combine its payment and revenue integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government and property and casualty markets. For more information, visit www.multiplan.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations<\/b>\n<\/p>\n

\nLuke Montgomery, CFA
\n
SVP, Finance and Investor Relations
\n
MultiPlan
\n
866-909-7427
\n
investor@multiplan.com<\/a>\n<\/p>\n

\nShawna Gasik
\n
AVP, Investor Relations
\n
MultiPlan
\n
866-909-7427
\n
investor@multiplan.com<\/a>\n<\/p>\n

\nMedia<\/b>\n<\/p>\n

\nPamela Walker
\n
AVP, Marketing & Communication
\n
MultiPlan
\n
781-895-3118
\n
press@multiplan.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–MultiPlan Corporation (NYSE:MPLN) (\u201cMultiPlan\u201d or the \u201cCompany\u201d), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, and hold its conference call that … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49779","6":"format-standard","7":"category-industry"},"yoast_head":"\nMultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–MultiPlan Corporation (NYSE:MPLN) (\u201cMultiPlan\u201d or the \u201cCompany\u201d), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, and hold its conference call that ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-18T21:02:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call\",\"datePublished\":\"2022-10-18T21:02:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/\"},\"wordCount\":350,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018006271\\\/en\\\/837314\\\/21\\\/MULTIPLAN_LOGO_RGB_300dpi.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/\",\"name\":\"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018006271\\\/en\\\/837314\\\/21\\\/MULTIPLAN_LOGO_RGB_300dpi.jpg\",\"datePublished\":\"2022-10-18T21:02:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018006271\\\/en\\\/837314\\\/21\\\/MULTIPLAN_LOGO_RGB_300dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018006271\\\/en\\\/837314\\\/21\\\/MULTIPLAN_LOGO_RGB_300dpi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–MultiPlan Corporation (NYSE:MPLN) (\u201cMultiPlan\u201d or the \u201cCompany\u201d), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, and hold its conference call that ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-18T21:02:11+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call","datePublished":"2022-10-18T21:02:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/"},"wordCount":350,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/","url":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/","name":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg","datePublished":"2022-10-18T21:02:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221018006271\/en\/837314\/21\/MULTIPLAN_LOGO_RGB_300dpi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/multiplan-corporation-announces-third-quarter-2022-earnings-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MultiPlan Corporation Announces Third Quarter 2022 Earnings Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49779"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49779\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}